Tiratricol（Cat No.:A000706), or TRIAC, is a thyroid hormone analog used to manage thyroid hormone resistance and certain thyroid-related conditions. It mimics the triiodothyronine (T3) action, helping regulate metabolism and support normal thyroid function. Tiratricol is sometimes prescribed for conditions like hypothyroidism and for patients who do not respond adequately to standard thyroid hormone replacement therapies. It has also been explored for its potential in reducing goiter size and treating thyroid cancer. While effective, its use requires careful monitoring due to the risk of side effects like heart palpitations and bone loss.
| Catalog Number | A000706 |
| CAS Number | 51-24-1 |
| Synonyms | 51-24-1; Triac; Triacana; 3,3/’,5-TRIIODOTHYROACETIC ACID; Tiratricolum |
| Molecular Formula | C14H9I3O4 |
| Purity | ≥95% |
| Storage | 3 years -20C powder |
| IUPAC Name | 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid |
| InChI | InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20) |
| InChIKey | UOWZUVNAGUAEQC-UHFFFAOYSA-N |
| SMILES | C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O |
